Global Hemoglobinopathy Treatment Drug Market Insights and Forecast to 2028

  • Report ID:256887
  • Industry Name: Medical Care
  • Publishing Date: Jul-22
  • No. of Pages: 111
                              
Hemoglobinopathy Treatment Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Hemoglobinopathy Treatment Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Analgesics Antibiotics ACE Inhibitors Hydroxyurea Others Segment by Application Hospital Pharmacy Retail Pharmacy Online Pharmacy By Company Bristol-Myers Squibb Company GlycoMimetics Pfizer Anthera Pharmaceuticals Eli Lilly and Company Mast Therapeutics Daiichi Sankyo Company Novartis Bluebird Bio HemaQuest Pharmaceuticals Emmaus Medical Prolong Pharmaceuticals Merck Medunik USA Sangamo Therapeutics Global Blood Therapeutics Alnylam Pharmaceuticals Acceleron Pharma By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemoglobinopathy Treatment Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Analgesics 1.2.3 Antibiotics 1.2.4 ACE Inhibitors 1.2.5 Hydroxyurea 1.2.6 Others 1.3 Market by Application 1.3.1 Global Hemoglobinopathy Treatment Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemoglobinopathy Treatment Drug Market Perspective (2017-2028) 2.2 Hemoglobinopathy Treatment Drug Growth Trends by Region 2.2.1 Hemoglobinopathy Treatment Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Hemoglobinopathy Treatment Drug Historic Market Size by Region (2017-2022) 2.2.3 Hemoglobinopathy Treatment Drug Forecasted Market Size by Region (2023-2028) 2.3 Hemoglobinopathy Treatment Drug Market Dynamics 2.3.1 Hemoglobinopathy Treatment Drug Industry Trends 2.3.2 Hemoglobinopathy Treatment Drug Market Drivers 2.3.3 Hemoglobinopathy Treatment Drug Market Challenges 2.3.4 Hemoglobinopathy Treatment Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemoglobinopathy Treatment Drug Players by Revenue 3.1.1 Global Top Hemoglobinopathy Treatment Drug Players by Revenue (2017-2022) 3.1.2 Global Hemoglobinopathy Treatment Drug Revenue Market Share by Players (2017-2022) 3.2 Global Hemoglobinopathy Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hemoglobinopathy Treatment Drug Revenue 3.4 Global Hemoglobinopathy Treatment Drug Market Concentration Ratio 3.4.1 Global Hemoglobinopathy Treatment Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Treatment Drug Revenue in 2021 3.5 Hemoglobinopathy Treatment Drug Key Players Head office and Area Served 3.6 Key Players Hemoglobinopathy Treatment Drug Product Solution and Service 3.7 Date of Enter into Hemoglobinopathy Treatment Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemoglobinopathy Treatment Drug Breakdown Data by Type 4.1 Global Hemoglobinopathy Treatment Drug Historic Market Size by Type (2017-2022) 4.2 Global Hemoglobinopathy Treatment Drug Forecasted Market Size by Type (2023-2028) 5 Hemoglobinopathy Treatment Drug Breakdown Data by Application 5.1 Global Hemoglobinopathy Treatment Drug Historic Market Size by Application (2017-2022) 5.2 Global Hemoglobinopathy Treatment Drug Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Hemoglobinopathy Treatment Drug Market Size (2017-2028) 6.2 North America Hemoglobinopathy Treatment Drug Market Size by Type 6.2.1 North America Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) 6.2.2 North America Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) 6.2.3 North America Hemoglobinopathy Treatment Drug Market Share by Type (2017-2028) 6.3 North America Hemoglobinopathy Treatment Drug Market Size by Application 6.3.1 North America Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) 6.3.2 North America Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) 6.3.3 North America Hemoglobinopathy Treatment Drug Market Share by Application (2017-2028) 6.4 North America Hemoglobinopathy Treatment Drug Market Size by Country 6.4.1 North America Hemoglobinopathy Treatment Drug Market Size by Country (2017-2022) 6.4.2 North America Hemoglobinopathy Treatment Drug Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Hemoglobinopathy Treatment Drug Market Size (2017-2028) 7.2 Europe Hemoglobinopathy Treatment Drug Market Size by Type 7.2.1 Europe Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) 7.2.2 Europe Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) 7.2.3 Europe Hemoglobinopathy Treatment Drug Market Share by Type (2017-2028) 7.3 Europe Hemoglobinopathy Treatment Drug Market Size by Application 7.3.1 Europe Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) 7.3.2 Europe Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) 7.3.3 Europe Hemoglobinopathy Treatment Drug Market Share by Application (2017-2028) 7.4 Europe Hemoglobinopathy Treatment Drug Market Size by Country 7.4.1 Europe Hemoglobinopathy Treatment Drug Market Size by Country (2017-2022) 7.4.2 Europe Hemoglobinopathy Treatment Drug Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size (2017-2028) 8.2 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Type 8.2.1 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Hemoglobinopathy Treatment Drug Market Share by Type (2017-2028) 8.3 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Application 8.3.1 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Hemoglobinopathy Treatment Drug Market Share by Application (2017-2028) 8.4 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Region 8.4.1 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Hemoglobinopathy Treatment Drug Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hemoglobinopathy Treatment Drug Market Size (2017-2028) 9.2 Latin America Hemoglobinopathy Treatment Drug Market Size by Type 9.2.1 Latin America Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) 9.2.2 Latin America Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) 9.2.3 Latin America Hemoglobinopathy Treatment Drug Market Share by Type (2017-2028) 9.3 Latin America Hemoglobinopathy Treatment Drug Market Size by Application 9.3.1 Latin America Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) 9.3.2 Latin America Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) 9.3.3 Latin America Hemoglobinopathy Treatment Drug Market Share by Application (2017-2028) 9.4 Latin America Hemoglobinopathy Treatment Drug Market Size by Country 9.4.1 Latin America Hemoglobinopathy Treatment Drug Market Size by Country (2017-2022) 9.4.2 Latin America Hemoglobinopathy Treatment Drug Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size (2017-2028) 10.2 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Type 10.2.1 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Hemoglobinopathy Treatment Drug Market Share by Type (2017-2028) 10.3 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Application 10.3.1 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Hemoglobinopathy Treatment Drug Market Share by Application (2017-2028) 10.4 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Country 10.4.1 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Hemoglobinopathy Treatment Drug Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bristol-Myers Squibb Company 11.1.1 Bristol-Myers Squibb Company Company Details 11.1.2 Bristol-Myers Squibb Company Business Overview 11.1.3 Bristol-Myers Squibb Company Hemoglobinopathy Treatment Drug Introduction 11.1.4 Bristol-Myers Squibb Company Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.1.5 Bristol-Myers Squibb Company Recent Developments 11.2 GlycoMimetics 11.2.1 GlycoMimetics Company Details 11.2.2 GlycoMimetics Business Overview 11.2.3 GlycoMimetics Hemoglobinopathy Treatment Drug Introduction 11.2.4 GlycoMimetics Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.2.5 GlycoMimetics Recent Developments 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Hemoglobinopathy Treatment Drug Introduction 11.3.4 Pfizer Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.3.5 Pfizer Recent Developments 11.4 Anthera Pharmaceuticals 11.4.1 Anthera Pharmaceuticals Company Details 11.4.2 Anthera Pharmaceuticals Business Overview 11.4.3 Anthera Pharmaceuticals Hemoglobinopathy Treatment Drug Introduction 11.4.4 Anthera Pharmaceuticals Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.4.5 Anthera Pharmaceuticals Recent Developments 11.5 Eli Lilly and Company 11.5.1 Eli Lilly and Company Company Details 11.5.2 Eli Lilly and Company Business Overview 11.5.3 Eli Lilly and Company Hemoglobinopathy Treatment Drug Introduction 11.5.4 Eli Lilly and Company Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.5.5 Eli Lilly and Company Recent Developments 11.6 Mast Therapeutics 11.6.1 Mast Therapeutics Company Details 11.6.2 Mast Therapeutics Business Overview 11.6.3 Mast Therapeutics Hemoglobinopathy Treatment Drug Introduction 11.6.4 Mast Therapeutics Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.6.5 Mast Therapeutics Recent Developments 11.7 Daiichi Sankyo Company 11.7.1 Daiichi Sankyo Company Company Details 11.7.2 Daiichi Sankyo Company Business Overview 11.7.3 Daiichi Sankyo Company Hemoglobinopathy Treatment Drug Introduction 11.7.4 Daiichi Sankyo Company Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.7.5 Daiichi Sankyo Company Recent Developments 11.8 Novartis 11.8.1 Novartis Company Details 11.8.2 Novartis Business Overview 11.8.3 Novartis Hemoglobinopathy Treatment Drug Introduction 11.8.4 Novartis Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.8.5 Novartis Recent Developments 11.9 Bluebird Bio 11.9.1 Bluebird Bio Company Details 11.9.2 Bluebird Bio Business Overview 11.9.3 Bluebird Bio Hemoglobinopathy Treatment Drug Introduction 11.9.4 Bluebird Bio Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.9.5 Bluebird Bio Recent Developments 11.10 HemaQuest Pharmaceuticals 11.10.1 HemaQuest Pharmaceuticals Company Details 11.10.2 HemaQuest Pharmaceuticals Business Overview 11.10.3 HemaQuest Pharmaceuticals Hemoglobinopathy Treatment Drug Introduction 11.10.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.10.5 HemaQuest Pharmaceuticals Recent Developments 11.11 Emmaus Medical 11.11.1 Emmaus Medical Company Details 11.11.2 Emmaus Medical Business Overview 11.11.3 Emmaus Medical Hemoglobinopathy Treatment Drug Introduction 11.11.4 Emmaus Medical Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.11.5 Emmaus Medical Recent Developments 11.12 Prolong Pharmaceuticals 11.12.1 Prolong Pharmaceuticals Company Details 11.12.2 Prolong Pharmaceuticals Business Overview 11.12.3 Prolong Pharmaceuticals Hemoglobinopathy Treatment Drug Introduction 11.12.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.12.5 Prolong Pharmaceuticals Recent Developments 11.13 Merck 11.13.1 Merck Company Details 11.13.2 Merck Business Overview 11.13.3 Merck Hemoglobinopathy Treatment Drug Introduction 11.13.4 Merck Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.13.5 Merck Recent Developments 11.14 Medunik USA 11.14.1 Medunik USA Company Details 11.14.2 Medunik USA Business Overview 11.14.3 Medunik USA Hemoglobinopathy Treatment Drug Introduction 11.14.4 Medunik USA Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.14.5 Medunik USA Recent Developments 11.15 Sangamo Therapeutics 11.15.1 Sangamo Therapeutics Company Details 11.15.2 Sangamo Therapeutics Business Overview 11.15.3 Sangamo Therapeutics Hemoglobinopathy Treatment Drug Introduction 11.15.4 Sangamo Therapeutics Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.15.5 Sangamo Therapeutics Recent Developments 11.16 Global Blood Therapeutics 11.16.1 Global Blood Therapeutics Company Details 11.16.2 Global Blood Therapeutics Business Overview 11.16.3 Global Blood Therapeutics Hemoglobinopathy Treatment Drug Introduction 11.16.4 Global Blood Therapeutics Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.16.5 Global Blood Therapeutics Recent Developments 11.17 Alnylam Pharmaceuticals 11.17.1 Alnylam Pharmaceuticals Company Details 11.17.2 Alnylam Pharmaceuticals Business Overview 11.17.3 Alnylam Pharmaceuticals Hemoglobinopathy Treatment Drug Introduction 11.17.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.17.5 Alnylam Pharmaceuticals Recent Developments 11.18 Acceleron Pharma 11.18.1 Acceleron Pharma Company Details 11.18.2 Acceleron Pharma Business Overview 11.18.3 Acceleron Pharma Hemoglobinopathy Treatment Drug Introduction 11.18.4 Acceleron Pharma Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) 11.18.5 Acceleron Pharma Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Hemoglobinopathy Treatment Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Analgesics Table 3. Key Players of Antibiotics Table 4. Key Players of ACE Inhibitors Table 5. Key Players of Hydroxyurea Table 6. Key Players of Others Table 7. Global Hemoglobinopathy Treatment Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 8. Global Hemoglobinopathy Treatment Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Hemoglobinopathy Treatment Drug Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Hemoglobinopathy Treatment Drug Market Share by Region (2017-2022) Table 11. Global Hemoglobinopathy Treatment Drug Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Hemoglobinopathy Treatment Drug Market Share by Region (2023-2028) Table 13. Hemoglobinopathy Treatment Drug Market Trends Table 14. Hemoglobinopathy Treatment Drug Market Drivers Table 15. Hemoglobinopathy Treatment Drug Market Challenges Table 16. Hemoglobinopathy Treatment Drug Market Restraints Table 17. Global Hemoglobinopathy Treatment Drug Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Hemoglobinopathy Treatment Drug Revenue Share by Players (2017-2022) Table 19. Global Top Hemoglobinopathy Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Treatment Drug as of 2021) Table 20. Ranking of Global Top Hemoglobinopathy Treatment Drug Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Hemoglobinopathy Treatment Drug Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Hemoglobinopathy Treatment Drug Product Solution and Service Table 24. Date of Enter into Hemoglobinopathy Treatment Drug Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Hemoglobinopathy Treatment Drug Revenue Market Share by Type (2017-2022) Table 28. Global Hemoglobinopathy Treatment Drug Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Hemoglobinopathy Treatment Drug Revenue Market Share by Type (2023-2028) Table 30. Global Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Hemoglobinopathy Treatment Drug Revenue Share by Application (2017-2022) Table 32. Global Hemoglobinopathy Treatment Drug Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Hemoglobinopathy Treatment Drug Revenue Share by Application (2023-2028) Table 34. North America Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 35. North America Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 36. North America Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 37. North America Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 38. North America Hemoglobinopathy Treatment Drug Market Size by Country (2017-2022) & (US$ Million) Table 39. North America Hemoglobinopathy Treatment Drug Market Size by Country (2023-2028) & (US$ Million) Table 40. Europe Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 41. Europe Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 42. Europe Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 43. Europe Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 44. Europe Hemoglobinopathy Treatment Drug Market Size by Country (2017-2022) & (US$ Million) Table 45. Europe Hemoglobinopathy Treatment Drug Market Size by Country (2023-2028) & (US$ Million) Table 46. Asia Pacific Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 47. Asia Pacific Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 48. Asia Pacific Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 49. Asia Pacific Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 50. Asia Pacific Hemoglobinopathy Treatment Drug Market Size by Region (2017-2022) & (US$ Million) Table 51. Asia Pacific Hemoglobinopathy Treatment Drug Market Size by Region (2023-2028) & (US$ Million) Table 52. Latin America Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 53. Latin America Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 54. Latin America Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 55. Latin America Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 56. Latin America Hemoglobinopathy Treatment Drug Market Size by Country (2017-2022) & (US$ Million) Table 57. Latin America Hemoglobinopathy Treatment Drug Market Size by Country (2023-2028) & (US$ Million) Table 58. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size by Type (2017-2022) & (US$ Million) Table 59. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size by Type (2023-2028) & (US$ Million) Table 60. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size by Application (2017-2022) & (US$ Million) Table 61. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size by Application (2023-2028) & (US$ Million) Table 62. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size by Country (2017-2022) & (US$ Million) Table 63. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size by Country (2023-2028) & (US$ Million) Table 64. Bristol-Myers Squibb Company Company Details Table 65. Bristol-Myers Squibb Company Business Overview Table 66. Bristol-Myers Squibb Company Hemoglobinopathy Treatment Drug Product Table 67. Bristol-Myers Squibb Company Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 68. Bristol-Myers Squibb Company Recent Developments Table 69. GlycoMimetics Company Details Table 70. GlycoMimetics Business Overview Table 71. GlycoMimetics Hemoglobinopathy Treatment Drug Product Table 72. GlycoMimetics Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 73. GlycoMimetics Recent Developments Table 74. Pfizer Company Details Table 75. Pfizer Business Overview Table 76. Pfizer Hemoglobinopathy Treatment Drug Product Table 77. Pfizer Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 78. Pfizer Recent Developments Table 79. Anthera Pharmaceuticals Company Details Table 80. Anthera Pharmaceuticals Business Overview Table 81. Anthera Pharmaceuticals Hemoglobinopathy Treatment Drug Product Table 82. Anthera Pharmaceuticals Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 83. Anthera Pharmaceuticals Recent Developments Table 84. Eli Lilly and Company Company Details Table 85. Eli Lilly and Company Business Overview Table 86. Eli Lilly and Company Hemoglobinopathy Treatment Drug Product Table 87. Eli Lilly and Company Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 88. Eli Lilly and Company Recent Developments Table 89. Mast Therapeutics Company Details Table 90. Mast Therapeutics Business Overview Table 91. Mast Therapeutics Hemoglobinopathy Treatment Drug Product Table 92. Mast Therapeutics Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 93. Mast Therapeutics Recent Developments Table 94. Daiichi Sankyo Company Company Details Table 95. Daiichi Sankyo Company Business Overview Table 96. Daiichi Sankyo Company Hemoglobinopathy Treatment Drug Product Table 97. Daiichi Sankyo Company Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 98. Daiichi Sankyo Company Recent Developments Table 99. Novartis Company Details Table 100. Novartis Business Overview Table 101. Novartis Hemoglobinopathy Treatment Drug Product Table 102. Novartis Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 103. Novartis Recent Developments Table 104. Bluebird Bio Company Details Table 105. Bluebird Bio Business Overview Table 106. Bluebird Bio Hemoglobinopathy Treatment Drug Product Table 107. Bluebird Bio Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 108. Bluebird Bio Recent Developments Table 109. HemaQuest Pharmaceuticals Company Details Table 110. HemaQuest Pharmaceuticals Business Overview Table 111. HemaQuest Pharmaceuticals Hemoglobinopathy Treatment Drug Product Table 112. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 113. HemaQuest Pharmaceuticals Recent Developments Table 114. Emmaus Medical Company Details Table 115. Emmaus Medical Business Overview Table 116. Emmaus Medical Hemoglobinopathy Treatment Drug Product Table 117. Emmaus Medical Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 118. Emmaus Medical Recent Developments Table 119. Prolong Pharmaceuticals Company Details Table 120. Prolong Pharmaceuticals Business Overview Table 121. Prolong Pharmaceuticals Hemoglobinopathy Treatment Drug Product Table 122. Prolong Pharmaceuticals Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 123. Prolong Pharmaceuticals Recent Developments Table 124. Merck Company Details Table 125. Merck Business Overview Table 126. Merck Hemoglobinopathy Treatment Drug Product Table 127. Merck Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 128. Merck Recent Developments Table 129. Medunik USA Company Details Table 130. Medunik USA Business Overview Table 131. Medunik USA Hemoglobinopathy Treatment Drug Product Table 132. Medunik USA Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 133. Medunik USA Recent Developments Table 134. Sangamo Therapeutics Company Details Table 135. Sangamo Therapeutics Business Overview Table 136. Sangamo Therapeutics Hemoglobinopathy Treatment Drug Product Table 137. Sangamo Therapeutics Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 138. Sangamo Therapeutics Recent Developments Table 139. Global Blood Therapeutics Company Details Table 140. Global Blood Therapeutics Business Overview Table 141. Global Blood Therapeutics Hemoglobinopathy Treatment Drug Product Table 142. Global Blood Therapeutics Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 143. Global Blood Therapeutics Recent Developments Table 144. Alnylam Pharmaceuticals Company Details Table 145. Alnylam Pharmaceuticals Business Overview Table 146. Alnylam Pharmaceuticals Hemoglobinopathy Treatment Drug Product Table 147. Alnylam Pharmaceuticals Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 148. Alnylam Pharmaceuticals Recent Developments Table 149. Acceleron Pharma Company Details Table 150. Acceleron Pharma Business Overview Table 151. Acceleron Pharma Hemoglobinopathy Treatment Drug Product Table 152. Acceleron Pharma Revenue in Hemoglobinopathy Treatment Drug Business (2017-2022) & (US$ Million) Table 153. Acceleron Pharma Recent Developments Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemoglobinopathy Treatment Drug Market Share by Type: 2021 VS 2028 Figure 2. Analgesics Features Figure 3. Antibiotics Features Figure 4. ACE Inhibitors Features Figure 5. Hydroxyurea Features Figure 6. Others Features Figure 7. Global Hemoglobinopathy Treatment Drug Market Share by Application: 2021 VS 2028 Figure 8. Hospital Pharmacy Case Studies Figure 9. Retail Pharmacy Case Studies Figure 10. Online Pharmacy Case Studies Figure 11. Hemoglobinopathy Treatment Drug Report Years Considered Figure 12. Global Hemoglobinopathy Treatment Drug Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Hemoglobinopathy Treatment Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Hemoglobinopathy Treatment Drug Market Share by Region: 2021 VS 2028 Figure 15. Global Hemoglobinopathy Treatment Drug Market Share by Players in 2021 Figure 16. Global Top Hemoglobinopathy Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Treatment Drug as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Hemoglobinopathy Treatment Drug Revenue in 2021 Figure 18. North America Hemoglobinopathy Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 19. North America Hemoglobinopathy Treatment Drug Market Size Market Share by Type (2017-2028) Figure 20. North America Hemoglobinopathy Treatment Drug Market Size Market Share by Application (2017-2028) Figure 21. North America Hemoglobinopathy Treatment Drug Market Size Share by Country (2017-2028) Figure 22. United States Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Hemoglobinopathy Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 25. Europe Hemoglobinopathy Treatment Drug Market Size Market Share by Type (2017-2028) Figure 26. Europe Hemoglobinopathy Treatment Drug Market Size Market Share by Application (2017-2028) Figure 27. Europe Hemoglobinopathy Treatment Drug Market Size Share by Country (2017-2028) Figure 28. Germany Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. France Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. U.K. Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Italy Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Russia Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Nordic Countries Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Hemoglobinopathy Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 35. Asia Pacific Hemoglobinopathy Treatment Drug Market Size Market Share by Type (2017-2028) Figure 36. Asia Pacific Hemoglobinopathy Treatment Drug Market Size Market Share by Application (2017-2028) Figure 37. Asia Pacific Hemoglobinopathy Treatment Drug Market Size Share by Region (2017-2028) Figure 38. China Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Japan Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. South Korea Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Southeast Asia Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. India Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Australia Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 44. Latin America Hemoglobinopathy Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 45. Latin America Hemoglobinopathy Treatment Drug Market Size Market Share by Type (2017-2028) Figure 46. Latin America Hemoglobinopathy Treatment Drug Market Size Market Share by Application (2017-2028) Figure 47. Latin America Hemoglobinopathy Treatment Drug Market Size Share by Country (2017-2028) Figure 48. Mexico Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Brazil Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Hemoglobinopathy Treatment Drug Market Size YoY (2017-2028) & (US$ Million) Figure 51. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size Market Share by Type (2017-2028) Figure 52. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size Market Share by Application (2017-2028) Figure 53. Middle East and Africa Hemoglobinopathy Treatment Drug Market Size Share by Country (2017-2028) Figure 54. Turkey Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. UAE Hemoglobinopathy Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 58. GlycoMimetics Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 59. Pfizer Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 60. Anthera Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 61. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 62. Mast Therapeutics Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 63. Daiichi Sankyo Company Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 64. Novartis Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 65. Bluebird Bio Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 66. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 67. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 68. Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 69. Merck Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 70. Medunik USA Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 71. Sangamo Therapeutics Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 72. Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 73. Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 74. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Treatment Drug Business (2017-2022) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.